LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.98 | 84.90 | 114 | 7257 | 0.0157 | 0.0470 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.98 | 84.90 | 4366 | 7257 | 0.6016 | 0.8477 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.98 | 84.90 | 5372 | 7257 | 0.7402 | 0.9084 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.98 | 84.90 | 5852 | 7257 | 0.8063 | 0.9340 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 84.90 | 51 | 7000 | 0.0073 | -0.0769 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 84.90 | 6079 | 7000 | 0.8684 | 0.9562 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 84.90 | 94 | 7000 | 0.0134 | 0.0161 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 84.90 | 4540 | 7000 | 0.6485 | 0.8685 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 84.90 | 5487 | 7000 | 0.7838 | 0.9249 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 84.90 | 5987 | 7000 | 0.8552 | 0.9515 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.66 | 84.90 | 628 | 285 | 2.1978 | 2.1358 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.66 | 84.90 | 597 | 285 | 2.0893 | 2.0465 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.36 | 84.90 | 713 | 322 | 2.2104 | 2.0192 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.36 | 84.90 | 680 | 322 | 2.1081 | 1.9458 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.06 | 84.90 | 814 | 365 | 2.2274 | 1.9254 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.06 | 84.90 | 761 | 365 | 2.0824 | 1.8333 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.77 | 84.90 | 852 | 411 | 2.0718 | 1.7543 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | L09 |